UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Determination of gluten consumption in celiac disease patients on a gluten-free diet

The American journal of clinical nutrition, 2018-02, Vol.107 (2), p.201-207

2018

Volltextzugriff (PDF)

Latiglutenase treatment for celiac disease: symptom and quality of life improvement for seropositive patients on a gluten‐free diet

GastroHep, 2019-11, Vol.1 (6), p.293-301

2019

Volltextzugriff (PDF)

Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge

Gastroenterology (New York, N.Y. 1943), 2022-12, Vol.163 (6), p.1510-1521.e6

2022

Volltextzugriff (PDF)

A Composite Morphometric Duodenal Biopsy Mucosal Scale for Celiac Disease Encompassing Both Morphology and Inflammation

Clinical gastroenterology and hepatology, 2024-06, Vol.22 (6), p.1238-1244.e3

2024

Volltextzugriff (PDF)

Novel aspects of quantitation of immunogenic wheat gluten peptides by liquid chromatography–mass spectrometry/mass spectrometry

Journal of Chromatography A, 2010-06, Vol.1217 (25), p.4167-4183

2010

Volltextzugriff (PDF)

Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S480-S480

2017

Volltextzugriff (PDF)

Evaluation of qualitative and quantitative immunoassays to detect barley contamination in gluten-free beer with confirmation using LC/MS/MS

Journal of AOAC International, 2014-11, Vol.97 (6), p.1615

2014

Volltextzugriff (PDF)

Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S163-S163

2017

Volltextzugriff (PDF)

Tu1357 MEASURING GLUTEN IN A CLINICAL TRIAL SETTING - EXPERIENCES WITH LATIGLUTENASE, AN ORAL THERAPY IN DEVELOPMENT FOR CELIAC DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1029-S-1029

2023

Volltextzugriff (PDF)

Tu1358 A COMPOSITE QUANTITATIVE HISTOLOGY SCALE BASED ON VH:CD AND IEL

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1029-S-1030

2023

Volltextzugriff (PDF)

Sa1258: GLUTEN IN URINE MEASUREMENTS VALIDATE LATIGLUTENASE MECHANISM OF ACTION IN CELIACSHIELD GLUTEN CHALLENGE: STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-357-S-358

2022

Volltextzugriff (PDF)

Mo1987 – Responder Analysis for Latiglutenase Reduction in Symptoms for Celiac Disease Patients

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-912-S-912

2019

Volltextzugriff (PDF)

Su1348 A COMPOSITE MUCOSAL SCALE FOR CELIAC DISEASE ENCOMPASSING BOTH MORPHOLOGY AND INFLAMMATION

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-739-S-740

2024

Volltextzugriff (PDF)

Su1335 DYNAMICS OF SEROLOGIC CHANGE TO GLUTEN IN CELIAC DISEASE PATIENTS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-734-S-734

2024

Volltextzugriff (PDF)

1085: CELIACSHIELDTM GLUTEN CHALLENGE STUDY – LATIGLUTENASE PROTECTS THE MUCOSA AND ATTENUATES SYMPTOMS OF CELIAC DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-252-S-253

2022

Volltextzugriff (PDF)

Su1134 - Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S480-S480

2017

Volltextzugriff (PDF)

Mo1986 – Latiglutenase Improves Quality of Life in Seropositive Celiac Disease Patients

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-912-S-912

2019

Volltextzugriff (PDF)

Mo1985 – Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-911-S-912

2019

Volltextzugriff (PDF)

Mo1044 - Correlation of Histologic, Serologic, and Symptomatic Measures of Celiac Disease Patients Participating in a Latiglutenase Clinical Trial

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-682-S-682

2018

Volltextzugriff (PDF)

Mo1045 - Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-682-S-682

2018

Volltextzugriff (PDF)

741e - Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S163-S163

2017

Volltextzugriff (PDF)

Novel aspects of quantitation of immunogenic wheat gluten peptides by liquid chromatography-mass spectrometry/mass spectrometry: Mass Spectrometry: Innovation and Application. Part VI

Journal of chromatography, 2010, Vol.1217 (25), p.4167-4183

2010

Volltextzugriff (PDF)

Investigation of immunogenic gluten peptides: Identification using enzymatic tagging and HPLC-MSn analysis and quantification using HPLC-MS/MS

Sealey-Voyksner, Jennifer A

2009

Volltextzugriff (PDF)

Discovery of highly conserved unique peanut and tree nut peptides by LC–MS/MS for multi-allergen detection

Food chemistry, 2016-03, Vol.194, p.201-211

2016

Volltextzugriff (PDF)

Dynamics of Serologic Change to Gluten in Celiac Disease Patients

Nutrients, 2023-12, Vol.15 (24), p.5083

2023

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)
Dissertationen
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determination of gluten consumption in celiac disease patients on a gluten-free diet

Latiglutenase treatment for celiac disease: symptom and quality of life improvement for seropositive patients on a gluten‐free diet

Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge

A Composite Morphometric Duodenal Biopsy Mucosal Scale for Celiac Disease Encompassing Both Morphology and Inflammation

Novel aspects of quantitation of immunogenic wheat gluten peptides by liquid chromatography–mass spectrometry/mass spectrometry

Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten

Evaluation of qualitative and quantitative immunoassays to detect barley contamination in gluten-free beer with confirmation using LC/MS/MS

Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients

Tu1357 MEASURING GLUTEN IN A CLINICAL TRIAL SETTING - EXPERIENCES WITH LATIGLUTENASE, AN ORAL THERAPY IN DEVELOPMENT FOR CELIAC DISEASE

Tu1358 A COMPOSITE QUANTITATIVE HISTOLOGY SCALE BASED ON VH:CD AND IEL

Sa1258: GLUTEN IN URINE MEASUREMENTS VALIDATE LATIGLUTENASE MECHANISM OF ACTION IN CELIACSHIELD GLUTEN CHALLENGE: STUDY

Mo1987 – Responder Analysis for Latiglutenase Reduction in Symptoms for Celiac Disease Patients

Su1348 A COMPOSITE MUCOSAL SCALE FOR CELIAC DISEASE ENCOMPASSING BOTH MORPHOLOGY AND INFLAMMATION

Su1335 DYNAMICS OF SEROLOGIC CHANGE TO GLUTEN IN CELIAC DISEASE PATIENTS

1085: CELIACSHIELDTM GLUTEN CHALLENGE STUDY – LATIGLUTENASE PROTECTS THE MUCOSA AND ATTENUATES SYMPTOMS OF CELIAC DISEASE

Su1134 - Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten

Mo1986 – Latiglutenase Improves Quality of Life in Seropositive Celiac Disease Patients

Mo1985 – Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients

Mo1044 - Correlation of Histologic, Serologic, and Symptomatic Measures of Celiac Disease Patients Participating in a Latiglutenase Clinical Trial

Mo1045 - Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients

741e - Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients

Novel aspects of quantitation of immunogenic wheat gluten peptides by liquid chromatography-mass spectrometry/mass spectrometry: Mass Spectrometry: Innovation and Application. Part VI

Investigation of immunogenic gluten peptides: Identification using enzymatic tagging and HPLC-MSn analysis and quantification using HPLC-MS/MS

Discovery of highly conserved unique peanut and tree nut peptides by LC–MS/MS for multi-allergen detection

Dynamics of Serologic Change to Gluten in Celiac Disease Patients

Suchergebnisse filtern